Sanofi
Cairn keen to take refund, drop cases
The firm termed 'bold' the legislation passed last month to cancel a 2012 policy that gave the tax department power to go back 50 years
COVID-19 vaccine to be priced below 10 euros: Sanofi
If the results are conclusive, Sanofi and GSK hope to get the vaccine approved in the first half of next year
US strikes a $2 billion deal for 100 million doses of coronavirus vaccine
The agreement calls for US to pay Sanofi and GlaxoSmithKline up to $2.1 billion to supply it with enough vaccines for 50 million people
France calls foul as Sanofi announce that US will get virus vaccine first
Sanofi sparked controversy after announcing that US patients would get their vaccine first as US government was helping to fund the vaccine
Sanofi, Regeneron skin cancer drug gets FDA approval
Drug, Libtayo, is used to treat a rare form of skin cancer, in patients whose condition has not improved following surgery or chemotherapy.
How Sanofi's setback could lead to better dengue vaccines
Next-generation vaccines by Japan’s Takeda and the U.S. National Institutes of Health are now in late-stage testing.